179 related articles for article (PubMed ID: 18988770)
1. Parstatin, the cleaved peptide on proteinase-activated receptor 1 activation, is a potent inhibitor of angiogenesis.
Zania P; Gourni D; Aplin AC; Nicosia RF; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2009 Feb; 328(2):378-89. PubMed ID: 18988770
[TBL] [Abstract][Full Text] [Related]
2. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
[TBL] [Abstract][Full Text] [Related]
3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
4. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
5. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model.
Becker CM; Sampson DA; Short SM; Javaherian K; Folkman J; D'Amato RJ
Fertil Steril; 2006 Jan; 85(1):71-7. PubMed ID: 16412733
[TBL] [Abstract][Full Text] [Related]
6. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone.
Varinska L; van Wijhe M; Belleri M; Mitola S; Perjesi P; Presta M; Koolwijk P; Ivanova L; Mojzis J
Eur J Pharmacol; 2012 Sep; 691(1-3):125-33. PubMed ID: 22721615
[TBL] [Abstract][Full Text] [Related]
8. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
[TBL] [Abstract][Full Text] [Related]
9. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
McGonigle JS; Giachelli CM; Scatena M
Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
[TBL] [Abstract][Full Text] [Related]
11. Decorin derived antiangiogenic peptide LRR5 inhibits endothelial cell migration by interfering with VEGF-stimulated NO release.
Fan H; Sulochana KN; Chong YS; Ge R
Int J Biochem Cell Biol; 2008; 40(10):2120-8. PubMed ID: 18373940
[TBL] [Abstract][Full Text] [Related]
12. Rational design, structure, and biological evaluation of cyclic peptides mimicking the vascular endothelial growth factor.
Goncalves V; Gautier B; Coric P; Bouaziz S; Lenoir C; Garbay C; Vidal M; Inguimbert N
J Med Chem; 2007 Oct; 50(21):5135-46. PubMed ID: 17900101
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
14. Comments on "Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis".
Di Serio C; Pellerito S; Tarantini F
J Pharmacol Exp Ther; 2008 Jan; 324(1):404-5; author reply 406-7. PubMed ID: 18094323
[No Abstract] [Full Text] [Related]
15. Adrenomedullin stimulates angiogenic response in cultured human vascular endothelial cells: involvement of the vascular endothelial growth factor receptor 2.
Guidolin D; Albertin G; Spinazzi R; Sorato E; Mascarin A; Cavallo D; Antonello M; Ribatti D
Peptides; 2008 Nov; 29(11):2013-23. PubMed ID: 18692535
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis.
Tong Y; Zhang X; Zhao W; Zhang Y; Lang J; Shi Y; Tan W; Li M; Zhang Y; Tong L; Lu H; Lin L; Ding J
Eur J Pharmacol; 2004 Jun; 494(2-3):101-9. PubMed ID: 15212963
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis by a novel small peptide consisting of the active fragments of platelet factor-4 and vasostatin.
Li X; Jiang L; Wang Y; Xiao Y; Huang Y; Yao Q; Yang Y; Wu X
Cancer Lett; 2007 Oct; 256(1):29-32. PubMed ID: 17574330
[TBL] [Abstract][Full Text] [Related]
18. Reduced ghrelin in endothelial cells plays important mechanistic role in aging-related impairment of angiogenesis.
Ahluwalia A; Li A; Cheng G; Deng X; Tarnawski AS
J Physiol Pharmacol; 2009 Jun; 60(2):29-34. PubMed ID: 19617642
[TBL] [Abstract][Full Text] [Related]
19. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
